Contact Precautions and Methicillin-Resistant Staphylococcus aureus—Modeling Our Way to Safety

Predicting the impact of contact precautions on methicillin-resistant Staphylococcus aureus outcomes: caution up ahead.

314When Should Contact Precautions be Discontinued for Patients with Methicillin-Resistant Staphylococcus aureus (MRSA)

Background. When to discontinue contact precautions (CP) for patients (pts) with MRSA remains unresolved and policies vary between hospitals. Our facility considers an MRSA patient positive (+) (and thus remaining in CP) until they have had two active surveillance cultures (ASC) return negative (-) or have undergone successful decolonization therapy. Methods. From October 2010-March 2014 we pro...

313Value of Discontinuation of Contact Precautions (CP) for Methicillin-Resistant Staphylococcus aureus (MRSA)

313. Value of Discontinuation of Contact Precautions (CP) for MethicillinResistant Staphylococcus aureus (MRSA) Erica S. Shenoy, MD, PhD; Hang Lee, PhD; Jessica Cotter, MPH; WinstonWare, MS; Douglas Kelbaugh, BS; Eric Weil, MD; Rochelle Walensky, MD, MPH, FIDSA; David Hooper, MD; Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA; Inf...

892Cost-Benefit Analysis of Universal Screening and Contact Precautions for Methicillin-resistant Staphylococcus aureus Carriers from the Hospital Perspective

for Methicillin-resistant Staphylococcus aureus Carriers from the Hospital Perspective James A. Mckinnell, MD; Sarah M. Bartsch, MPH; Bruce Lee, MD, MBA; Susan S. Huang, MD, MPH, FIDSA; Loren Miller, MD, MPH; Torrance Memorial Medical Center, Torrance, CA; Infectious Disease Clinical Outcomes Research Unit at Los Angeles Biomedical Research Institute, Torrance, CA; Public Health Computational a...

Isolation Precautions for Methicillin-Resistant Staphylococcus aureus: Electronic Surveillance to Monitor Adherence.

The Centers for Disease Control and Prevention recently updated guidelines for isolation precautions and added specific recommendations for the management of multidrug-resistant organisms. However, the extent to which these recommendations are followed is unknown. Although the recommendations are based on studies with high internal validity, the effectiveness of these interventions in clinical ...